Corvus Pharmaceuticals Inc (CRVS)

Capital Expenditure

-$698.00K

TTM · Period ending: · USD

CRVS logo

CRVS Capital Expenditure

Latest reported-$698.00K
CRVS TTM CapEx (-$1.75M → -$698.00K)
High-resolution chart · PNG

CRVS capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Corvus Pharmaceuticals Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-698,000
-229,000
-174,000
-149,000
-149,000
-36,000
0
0
0
0
-34,000
-38,000
-303,000
-307,000
-273,000
-274,000
-9,000
-5,000
-5,000
0
-76,000
-76,000
-76,000
-81,000
-9,000
-9,000
-25,000
-155,000
-311,000
-365,000
-355,000
-212,000
-94,000
-161,000
-266,000
-887,000
-944,000
-1,696,000
-2,199,000
-2,450,000
-2,357,000
-2,037,000
-1,747,000
-883,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.